In a significant development, biochemical company Amyris Inc. received judicial approval to reimburse attorney fees, up to an amount of $750,000, for an ad hoc group of creditors. This group holds close to $450 million of Amyris’ unsecured debt. The approval came from a Delaware bankruptcy judge on Thursday. Not much more information is currently available due to the ongoing case.
This action reflects the prevalent practice among businesses to compensate attorney fees of creditors, particularly in complex bankruptcies. Such arrangements typically aim to facilitate a smoother process and prompt resolution of the proceedings.
For the uninitiated, Amyris Inc. is a chemical sector corporation, involved in applying its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules. These molecules are utilised in a wide array of products across diverse markets such as health and wellness, clean beauty, and flavor and fragrance.
Fill in the details of this case and the broader implications for the legal landscape by following the development at Law360.